News
-
From Langya to Wetland to ALTNV: Macro & Micro-Test’s Emerging Pathogen Discovery Toolkit Supports a Third NEJM Publication
On September 3, 2026, The New England Journal of Medicine (NEJM) published a correspondence reporting the discovery of Asian longhorned tick nairovirus (ALTNV), a novel tick-borne orthonairovirus identified by a research team from the State Key Laboratory of Pathogen and Biosecurity, Beijing. Th...Read more -
From Infection to Sepsis: Why Diagnostic Readiness Across Multiple Infection Pathways Matters
Sepsis Remains a Global Health Emergency Sepsis remains one of the most serious global health challenges. According to the World Health Organization (WHO), an estimated 48.9 million cases of sepsis and 11 million sepsis-related deaths were reported globally in 2017, accounting for approximately o...Read more -
HMPV at 25: From a Forgotten Virus to the Challenge of Precision Diagnosis
2026 marks the 25th anniversary of the discovery of human metapneumovirus (HMPV). In 2001, a research team led by Dutch virologist Albert Osterhaus first isolated HMPV from nasopharyngeal aspirates collected from infants with respiratory infections. Yet HMPV was not truly a “new” virus. Subsequen...Read more -
Every Body. Every Need. Better Sexual Health Through Better Diagnostics.
September 4 marks World Sexual Health Day 2026. This year’s theme, “Every Body,” reminds us of an important fact: Sexual health is not one-size-fits-all. People have different health needs. Communities face different testing challenges. Healthcare providers require different levels of diagn...Read more -
Sertio Oy Chairman & CEO Mikko Soikkeli Visits Macro & Micro-Test to Strengthen IVDR Collaboration and Present New Certificates
Sertio Oy Chairman & CEO Mikko Soikkeli Visits Macro & Micro-Test to Strengthen IVDR Collaboration and Present New Certificates Suzhou, China – Mikko Soikkeli, Chairman and CEO of Sertio Oy, recently visited Macro & Micro-Test. During the visit, the two parties held in-depth discussio...Read more -
Macro & Micro-Test Comprehensive Dengue Testing Solutions -From Rapid Screening to Precision Diagnosis and Outbreak Surveillance
Macro & Micro-Test Comprehensive Dengue Testing Solutions -From Rapid Screening to Precision Diagnosis and Outbreak Surveillance Dengue is no longer a localized tropical disease. Its geographic range and public health impact continue to expand, creating growing demands for early detect...Read more -
When Fungal Infections Get Complex: Rethinking Comprehensive Molecular Detection
When Fungal Infections Get Complex: Rethinking Comprehensive Molecular Detection From Pathogen Identification to a Broader Molecular Picture Fungal infections can be difficult to diagnose. Clinical manifestations are often nonspecific, while conventional culture may require time to provide actio...Read more -
From Molecular Response to Long-Term Disease Control: The Clinical Value of BCR-ABL1 Quantification in CML
The introduction of tyrosine kinase inhibitors (TKIs) has transformed chronic myeloid leukemia (CML) from a life-threatening disease into a long-term manageable condition. Today, effective CML management goes beyond controlling disease progression—it increasingly focuses on achieving and maintain...Read more -
EML4-ALK Fusion Testing in NSCLC: Guideline- Recommended Molecular Diagnosis for Precision Therapy
EML4-ALK Fusion Testing in NSCLC: Guideline- Recommended Molecular Diagnosis for Precision Therapy Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of all lung cancer cases. Over the past d...Read more -
Beyond Infection: Toward a Comprehensive Understanding of Women’s Vaginal Health
Vaginal health is far more than the presence or absence of pathogens. The vaginal environment is a dynamic ecosystem influenced by the interaction between microbial communities, opportunistic microorganisms, host factors, and antimicrobial resistance mechanisms. Changes within this ecosystem may ...Read more -
Unlock Precision Treatment for NSCLC with Guideline-Recommended EGFR Mutation Testing
Lung cancer remains one of the world’s leading causes of cancer-related mortality, with non-small cell lung cancer (NSCLC) accounting for more than 80% of all lung cancer cases. In 2020 alone, more than 2.2 million new lung cancer cases were diagnosed worldwide As precision oncology contin...Read more -
Outbreak of Group C Rotavirus in a Primary School in Luzhou, China, and Macro & Micro-Test’s Whole-Genome Sequencing Technology Enables Precise Source Tracing
Recently, China CDC Weekly published an important research article describing the epidemiological and etiological investigation of an acute gastroenteritis outbreak caused by Group C rotavirus (RVC) at a primary school in Luzhou, Sichuan Province, in October 2025. Notably, Macro & Micro-Test’...Read more